| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b057fddee6645785fc5df7006be3bb3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-721 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-721 |
| filingDate |
2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e499d333ebfadce8f51ac7354b0bc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49bb10cbbd55a1c5ecf3037d5b3f06b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50ac9eae4455395367d13b41eab37a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c20be239ac2eb08669c8db4fd4786078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d75bb2b286f3cecee6f03d3d340b2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e363d8b8b2e37fd68e3908d93542375 |
| publicationDate |
2017-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017175132-A1 |
| titleOfInvention |
The use of cationic derivative of dextran for inhibition of herpes simplex viruses |
| abstract |
The use of dextran cationically modified by quaternary ammonium groups of structure I for the treatment and prophylaxis of diseases caused by herpes simplex viruses, wherein dextran is modified using glycidyltrimethylammonium chloride (GTMAC). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019177475-A1 |
| priorityDate |
2016-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |